about
Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherenceTolerability and efficacy of the intestinal phosphate binder Lantharenol® in cats.Magnesium carbonate-containing phosphate binder prevents connective tissue mineralization in Abcc6(-/-) mice-potential for treatment of pseudoxanthoma elasticumLanthanum carbonate for the treatment of hyperphosphatemia in CKD 5D: multicenter, double blind, randomized, controlled trial in mainland China.Management of hyperphosphataemia in chronic kidney disease-challenges and solutionsPreclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Lanthanum carbonate.
@en
Lanthanum carbonate.
@nl
type
label
Lanthanum carbonate.
@en
Lanthanum carbonate.
@nl
prefLabel
Lanthanum carbonate.
@en
Lanthanum carbonate.
@nl
P2093
P2860
P356
P1476
Lanthanum carbonate.
@en
P2093
Abhijit Kshirsagar
Corina Candiani
Joanna Q Hudson
Melanie S Joy
Tyson Brooks
P2860
P304
P356
10.1345/APH.1G224
P407
P577
2006-01-31T00:00:00Z